Interventional Oncology Market by Cancer (Lung, Kidney, Liver, Bone Metastasis), by Product (cryoablation, Radiofrequency, microwave, guidewires, embolization), by Procedures (Non-Thermal Ablation, Thermal Ablation, TARE, TAE, TACE) – 2024 to 2029

TABLE OF CONTENT

1 Global Interventional Oncology Market
1.1 Study Pharmaceutical Drug Delivery Market
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Interventional Oncology Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Interventional Oncology Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Interventional Oncology Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Interventional Oncology Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Interventional Oncology Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Interventional Oncology Market – By Component (Market Size – & million/billion)
8.1 Embolization Devices
8.2 Ablation Devices
8.3 Support Devices

9 Global Interventional Oncology Market – By Procedure
9.1 Thermal Tumor Ablation
9.2 Non-thermal Tumor Ablation
9.3 Transcatheter Arterial Chemoembolization (TACE)
9.4 Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy
(SIRT)
9.5 Transcatheter Arterial Embolization (TAE) or Bland Embolization

10 Global Interventional Oncology Market – By Type
10.1 Liver Cancer
10.2 Kidney Cancer
10.3 Lung Cancer
10.4 Bone Cancer
10.5 Other

11 Global Interventional Oncology Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Interventional Oncology Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Interventional Oncology Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Healthtronics, Inc.
13.3 Trod Medical
13.4 Sanarus Technologies, Inc.
13.5 Teleflex, Inc.
13.6 Imbiotechnologies Ltd.
13.7 Medtronic PLC
13.8 BTG PLC
13.9 Medwaves, Inc.
13.10 Icecure Medical
13.11 Terumo Corporation
13.12 Company 11 & more

14 Global Interventional Oncology Market – Appendix
14.1 Sources
14.2 Abbreviations